That study showed that, for people with overweight or obesity taking a GLP-1, the risk of the incident (new occurrence) of suicidal ideation is almost 75% lower, and the risk of it happening again (recurrence) is over 50% lower
(14) A potential reduction in hot flashes and night sweats which may be linked to improvements in metabolic health (5)
The combination has been associated with elevated sirtuin activity, altered adipocyte differentiation markers, and changes in muscle stem cell quiescence and proliferation in the cited preclinical literature
According to a clinical trial conducted by Dastan et al
Many patients experience appetite rebound once the medication is discontinued, which makes sustained weight loss difficult
Given Dihexas experimental nature, obtaining expert guidance is critical to minimize potential risks